MicroRNAs in Rheumatoid Arthritis: What is the Latest with Regards to Diagnostics?
Overview
Authors
Affiliations
Impact of miR-155 rs767649 Polymorphism on Rheumatoid Arthritis Activity in Egyptian Patients.
Elghouneimy M, Ramadan M, Farrag E, Ibrahim H, Khirala S, Seliem N Cureus. 2024; 15(11):e49297.
PMID: 38351964 PMC: 10862083. DOI: 10.7759/cureus.49297.
MicroRNAs-mediated regulation pathways in rheumatic diseases.
Assadiasl S, Rajabinejad M, Soleimanifar N, Makiyan F, Azizi E, Rezaiemanesh A Inflammopharmacology. 2022; 31(1):129-144.
PMID: 36469219 DOI: 10.1007/s10787-022-01097-6.
Islam Z, Baneen U, Khaliq T, Nurulain S, Muneer Z, Hussain S Clin Exp Med. 2022; 23(5):1667-1675.
PMID: 36303006 DOI: 10.1007/s10238-022-00916-y.
-Omic Approaches and Treatment Response in Rheumatoid Arthritis.
Madrid-Paredes A, Martin J, Marquez A Pharmaceutics. 2022; 14(8).
PMID: 36015273 PMC: 9412998. DOI: 10.3390/pharmaceutics14081648.
MicroRNAs (miRNAs) in Cardiovascular Complications of Rheumatoid Arthritis (RA): What Is New?.
Tanase D, Gosav E, Petrov D, Teodorescu D, Buliga-Finis O, Ouatu A Int J Mol Sci. 2022; 23(9).
PMID: 35563643 PMC: 9101033. DOI: 10.3390/ijms23095254.